期刊文献+

氨基肽酶的测定及临床意义 被引量:3

Determination and clinical significance of aminopeptidease
暂未订购
导出
摘要 目的测定氨基肽酶中的一种酶(亮氨酸氨基肽酶,LAP)作为临床肝胆疾病的诊断指标并探讨氨基肽酶的临床意义,以便于系统探讨此类酶的临床应用价值。方法以亮氨酰对硝基苯胺为底物,在405 nm下进行连续监测并对健康体检者及患者标本进行测定。结果线性范围至少为0-180 U.L-1,批内不精密度为2.9%,批间不精密度为5.6%;适用于各种自动生化分析仪。测定亮氨酰氨基肽酶的最适条件:选用浓度为125 mmol.L-1的Tris-Hcl缓冲液,最适pH为7.2,温度取37℃,得出在此实验条件下的米氏常数Km为0.15 mmol.L-1,亮氨酰对硝基苯胺浓度取6.0 mmol.L-1,取健康体检者血清157例(男81例,女76例),测得x—±s为35.7 U.L-1+8.2 U.L-1,建立了适合于临床应用及自动生化分析仪的方法和参考值。结论本法是检测肝胆疾病的可靠、稳定、快速的方法之一,对肝胆疾病的早期诊断和治疗起一定的作用;氨基肽酶可以作为多种疾病的临床诊断和监测指标。 Objective Aminopeptidease is a proteolytie enzyme, leueine aminopeptideas(LAP) is one kind of aminopeptidease, leueine aminopeptideas used as an assistant diagnosis for diseases in liver and gallbladder and explore the elirtieal significance and clinical value of aminopeptidease.Methods The method presented here uses leucylparanitroanilinum as the substrate, and can continuously monitor in 405 nm, detected serum samples of health people and patient. Results It gives out report:linearity range was at least 0- 180 U· L^-1, the intra and interassay were 2.9% and 5.6% respectively. This method is suitable to the various automatic biochemistry analyzers. Here we found the optimum situation to determine LAP:the concentration of Tris-HCl is 125 retool. L^-1 and the optimum pH is 7.2, temperature is 37 ℃, under this condition, Michaelis constant (Km ) is 0.15 mmol· L^-1, ground substance concentration is 6.0 mmol·L^-1 ,with 157 health people serum samples (81 from male,76 from female),^- x ± s= 35.7 U·L^-1 ± 8. 2 U· L^- 1,we established the method and reference value for clinical application and automatic analysis. Conclusion The operation is a concise, stable and speediness method to detect diseases in liver and gallbladder, It will be a method to help diagnosing diseases in liver and gallbladder; Aminopeptidease are useful index for the diagnosis and treatment of different disease.
出处 《中国实验诊断学》 2006年第12期1483-1485,共3页 Chinese Journal of Laboratory Diagnosis
关键词 氨基肽酶 肝胆疾病 诊断指标 Aminopeptidease diseases in liver and gallbladder index of diagnosis
  • 相关文献

参考文献9

  • 1Taylor A.Aminopeptidase:structure and function[J].FASEB J.1993,7,290.
  • 2Shikai K,Akedo H.A multienzyme complex in serum of hepatic cancer[J].Cancer Res,1972,32:2307.
  • 3Goldberg JJ.Colorimetric determination of leucine aminopeptidase in urine and serum of normal subjects and patient with cancer and other disease[J].Cancer,1985,11:283.
  • 4Taylor A,Peltier CZ,Torre FJ,et al.Inhibition of bovine lens leucine aminopeptidase by bestatin:number of binding sites and slow binding of this inhibitor[J].Biochemistry,1993,32(3):784.
  • 5Honami Kobayashi,Seiji Nomura,Takashi Mitsui,et al,Tissue distribution of placental leucine aminopeptidase/oxytocinase during mouse pregnancy.Journal of Histochemistry & Cytochemistry[J].2004,52(1):113.
  • 6Hutchinson DR,Hallwell RP,Lockhart JDF,et al,Glycylprolyl-p-nitroanilidase in hepatobiliary disease[J].Clin Chm Acta,1981,109:83.
  • 7王念跃,常伟.血清甘氨酰脯氨酸二肽氨基肽酶连续监测法测定[J].上海医学检验杂志,1995,10(1):28-29. 被引量:4
  • 8Hattori A,Kitatani K,Matsumoto,et al,Characterization of recombinant human adipocyte-derived leucine aminopeptidase expressed in Chinese hamster ovary cells[J].J Biochem (Tokyo),2000,128,755.
  • 9Yoshikuni Goto,Akira Hattori,Yasuhiro Ishii,et al.Reduced activity of the hypertension-associated Lys 528 Arg mutant of human adipocyte-derived leucine aminopeptidase (A-LAP)/ER-aminopeptidase-1[J].FEBS letters,2006,1833.

共引文献3

同被引文献19

  • 1孙志强,毛远丽,陈小倩,刘立明,郭静霞,杨静.八项生化指标在肝病诊断中的意义及临床评价[J].中华检验医学杂志,2005,28(8):813-816. 被引量:20
  • 2BAUVOIS B,DAUZONNE D.Aminopeptidase-N/CD13(EC 3.4.11.2)inhibitors:chemistry,biological evalua-tions,and therapeutic prospects[J].Med.Res.Rev.,2006,26(1):88-130.
  • 3ANTCZAK C,MEESTER I D,BAUVOIS B.Ectopeptidas-es in pathophysiology[J].Bioessays,2001,23(3):251-260.
  • 4SAIKI I,YONEDA J,AZUMA I,et al.Role of aminopep-tidase N(CD13)in tumor-cell invasion and extracellularmatrix degradation[J].Int.J.Cancer,1993,54(1):137-143.
  • 5SU Li,FANG Hao,YANG Kang-hui,et al.Design,syn-thesis and biological evaluation of novel L-lysine ureidoderivatives as aminopetidase N inhibitors[J].Bioorg.Med.Chem.,2011,19(2):900-906.
  • 6PREMARATHNE A A A,LEUNG D M.Characterizationof activity of a potential food-grade leucine aminopeptid-ase from kiwifruit[J].Enzyme Res.,2010:1-5.
  • 7GREMBECKA J,MUCHA A,CIERPICKI T,et al.Themost potent organophosphorus inhibitors of leucine amin-opeptidase.Structure-based design,chemistry,and activi-ty[J].J.Med.Chem.,2003,46(13):2 641-2 655.
  • 8PESCHKE W.Process for preparingα-Amino acid p-ni-troanilides:DE,1 243 204B[P].1967-06-29.
  • 9Taylor A.Aminopeptidase:structure and function[J].FASEB J,1993,7(2):290-298.
  • 10Jiro A.,Yoshiko U.,Masaki I.,et al.Alteration of Leucine Aminop-eptidase from Streptomyces septatus TH-2to PhenylalanineAminopeptidase by Site-Directed Mutagenesis[J].Appl Environ Microbiol,2005,71(11):7229-7235.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部